SITAGLU MET 50/850MG TAB

SITAGLU MET 50/850MG is a combination tablet containing Sitagliptin 50mg and Metformin HCL 850mg. This dual-action medication is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms. Sitagliptin works by increasing insulin release when blood glucose levels are elevated, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Together, these active ingredients provide comprehensive glycemic management. Suitable for patients whose diabetes is not adequately controlled with diet and exercise alone, or those already on monotherapy requiring additional glucose-lowering support. Always use as directed by your healthcare provider.